Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: a retrospective cohort study

Fig. 5

Kaplan–Meier survival curves. A, B PFS and OS between patients received SOX plus apatinib and SOX in conversion therapy. C, D PFS and OS of R0 resection, non-R0 resection and conversion failure group. E, F PFS and OS of conversion success group and conversion failure group. PFS, progression-free survival; OS, overall survival; SOX, oxaliplatin/S-1

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us